Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
about
Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis."Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.miR-335 inhibited cell proliferation of lung cancer cells by target Tra2β.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
P2860
Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Transformer 2β (Tra2β/SFRS10) ...... promoting cell proliferation.
@en
type
label
Transformer 2β (Tra2β/SFRS10) ...... promoting cell proliferation.
@en
prefLabel
Transformer 2β (Tra2β/SFRS10) ...... promoting cell proliferation.
@en
P2093
P2860
P1476
Transformer 2β (Tra2β/SFRS10) ...... promoting cell proliferation.
@en
P2093
Buyou Chen
Guoxin Mao
Tingting Ni
Xiaoning Lu
Xuefan Cui
P2860
P304
P356
10.1007/S10735-014-9582-3
P577
2014-06-21T00:00:00Z